There used to be no specific treatments for heart failure with preserved ejection fraction, but recent clinical trials show ...

Higher stages of cardiovascular-kidney-metabolic syndrome may correlate to increased risk of cardiovascular mortality, according to a longitudinal study of U.S. adults.“The study underscores a graded ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

“Kidney disease can affect anyone, but certain groups are at higher risk,” says Dr. Louise Moist, William F. Clark chair of ...

Revelation Biosciences doses first patient in PRIME phase 1b study of Gemini in CKD patients: San Diego, California Friday, February 28, 2025, 18:00 Hrs [IST] Revelation Bioscienc ...

Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.